Xbrane Biopharma AB Capital Reinvestment Ratio
Xbrane Biopharma AB capital reinvestment ratio. Xbrane Biopharma AB (XBRANE) has a Capital Reinvestment Ratio of 0.18x as of December 2024, meaning it reinvests 0% of its operating cash flow (Skr93.91 Million) in capital expenditures (Skr17.30 Million). Check cash flow reinvestment rate of Xbrane Biopharma AB to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Xbrane Biopharma AB (2018–2018)
Capital reinvestment ratio of Xbrane Biopharma AB from 2018 to 2018. This chart tracks Xbrane Biopharma AB's Capital Reinvestment Ratio across 1 annual periods. Also explore Xbrane Biopharma AB annual equity growth to track the company's year-over-year net asset growth rate.
Xbrane Biopharma AB Capital Reinvestment Ratio by Year (2018–2018)
Xbrane Biopharma AB capital reinvestment ratio by year from 2018 to 2018. For the full cash flow conversion analysis, see cash efficiency ratio of Xbrane Biopharma AB.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.03x | Skr46.71 Million | Skr1.60 Million | — |